For research purposes only. Not for human consumption. For use by licensed researchers only.
Semaglutide is a long-acting GLP-1 receptor agonist with structural modifications that extend its half-life to approximately one week. It has been one of the most extensively studied metabolic compounds for its effects on glycemic control, weight management, and cardiovascular risk reduction.
Mechanism of Action
Semaglutide binds to GLP-1 receptors in the pancreas, brain, and peripheral tissues, stimulating glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying. Its fatty acid side chain enables albumin binding to extend half-life. Research also indicates central nervous system effects on appetite and satiety through hypothalamic receptor activation.
Research Applications
- Type 2 diabetes and glycemic control research
- GLP-1 receptor agonism and downstream signaling studies
- Obesity and weight reduction mechanism research
- Cardiovascular risk and inflammation models
- Central nervous system appetite regulation studies
Research Grade Peptide
| Compound | Semaglutide |
| Strength | 10 MG |
| Vial Size | 6 ML |
| Vial Color | Amber |
| Form | Lyophilized Powder |
| Purity | >98% (HPLC verified) |
| Price | $250 |
This compound is provided strictly for in vitro and laboratory research. Not intended for human or animal use.